Clinical trials
Acute Coronary Syndrome trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 5 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 10 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sheba Medical Center | 7 |
| Bristol-Myers Squibb | 3 |
| Sanofi | 3 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Hillel Yaffe Medical Center | 2 |
| Angioslide Ltd. | 1 |
| AstraZeneca | 1 |
| Bar-Ilan University, Israel | 1 |
| Biotronik, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 39 |
| Angina, Unstable | 5 |
| Coronary Artery Disease | 5 |
| Myocardial Infarction | 5 |
| Non-ST Elevated Myocardial Infarction | 4 |
| ST Elevation Myocardial Infarction | 4 |
| Cardiovascular Diseases | 3 |
| Chest Pain | 3 |
| Coronary Disease | 3 |
| Heart Diseases | 3 |
Trials
Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.